Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $794000.0.

  • Healthstream's Share-based Compensation fell 2979.66% to $794000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1015.59%. This contributed to the annual value of $4.5 million for FY2024, which is 763.3% up from last year.
  • Per Healthstream's latest filing, its Share-based Compensation stood at $794000.0 for Q3 2025, which was down 2979.66% from $836000.0 recorded in Q2 2025.
  • Over the past 5 years, Healthstream's Share-based Compensation peaked at $3.0 million during Q4 2021, and registered a low of $616000.0 during Q1 2021.
  • For the 5-year period, Healthstream's Share-based Compensation averaged around $1.1 million, with its median value being $945000.0 (2022).
  • Per our database at Business Quant, Healthstream's Share-based Compensation surged by 45126.81% in 2021 and then crashed by 6894.51% in 2022.
  • Healthstream's Share-based Compensation (Quarter) stood at $3.0 million in 2021, then tumbled by 68.95% to $945000.0 in 2022, then grew by 13.97% to $1.1 million in 2023, then rose by 10.03% to $1.2 million in 2024, then plummeted by 33.0% to $794000.0 in 2025.
  • Its Share-based Compensation stands at $794000.0 for Q3 2025, versus $836000.0 for Q2 2025 and $1.1 million for Q1 2025.